Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trial
European Journal of Cancer · 2025-10 · 229 · 115731
DOI: 10.1016/j.ejca.2025.115731 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift European Journal of Cancer, 2025-10. Verfasst von Chantal F Stockem und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Ipilimumab, Lymph Nodes, Nivolumab. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Bristol-Myers Squibb Company.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands.
- Bioimaging Facility, Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Core Facility Molecular Pathology & Biobanking, Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Department of Urology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Förderung
- Bristol-Myers Squibb Company
Zitieren
APA
Stockem, C. F., van Dorp, J., van Dijk, N., Vis, D. J., Harkes, R., van den Broek, B., Alkemade, M., Broeks, A., Hendricksen, K., Boellaard, T. N., de Feijter, J. M., van Montfoort, M. L., Daletzakis, A., van der Heijden, A. G., Meijer, R. P., Mehra, N., Wessels, L. F. A., van Rhijn, B. W. G., Suelmann, B. B. M., & van der Heijden, M. S. (2025). Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trial. European Journal of Cancer, 229, 115731. https://doi.org/10.1016/j.ejca.2025.115731
Vancouver
Stockem CF, van Dorp J, van Dijk N, Vis DJ, Harkes R, van den Broek B, et al. Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trial. European Journal of Cancer. 2025;229:115731. doi:10.1016/j.ejca.2025.115731
BibTeX
@article{Stockem2025,
author = {Stockem, Chantal F and van Dorp, Jeroen and van Dijk, Nick and Vis, Daniel J and Harkes, Rolf and van den Broek, Bram and Alkemade, Maartje and Broeks, Annegien and Hendricksen, Kees and Boellaard, Thierry N and de Feijter, Jeantine M and van Montfoort, Maurits L and Daletzakis, Antonios and van der Heijden, Antoine G and Meijer, Richard P and Mehra, Niven and Wessels, Lodewyk F A and van Rhijn, Bas W G and Suelmann, Britt B M and van der Heijden, Michiel S},
title = {Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trial},
journal = {European Journal of Cancer},
year = {2025},
volume = {229},
pages = {115731},
doi = {10.1016/j.ejca.2025.115731}
}
EUVIMED